Utilizing our unique biosensor, NDT has completed development of a novel platform and system that can be applied to the human diagnostic, veterinary diagnostic, food safety, and environment biomarker detection markets.
Our current focus is on the human infectious disease detection market. This platform easily fits within the clinical lab or at near-patient testing locations.
According to Kalorama, the U.S. market for infectious disease diagnostics was $7.7B in 2008 and is projected to grow to $11.2B by 2013.